Lidanserin is primarily investigated for its potential applications in the field of pharmacology, particularly in the treatment of cardiovascular conditions. It has been studied for its ability to act as a serotonin antagonist, which may help in managing hypertension and other related disorders. Research suggests that it could be effective in reducing blood pressure by blocking specific serotonin receptors that contribute to vascular constriction. Additionally, its properties are being explored for potential use in addressing certain psychiatric conditions, such as anxiety or depression, where serotonin modulation plays a key role. However, its clinical applications are still under investigation, and further studies are required to establish its efficacy and safety in therapeutic settings.